| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Kala Bio, Inc. (KALA) has 7 insiders with recent SEC Form 4 filings, including 4 buys and 0 sells. KALA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 103.5K | $365.5K | - | |
| 10% | 46.5K | $164.1K | - | |
| Other | 41.8K | $147.4K | - | |
| Other | 36.0K | $126.9K | - | |
| Dir | 35.9K | $126.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 25, 2017 | Shah Rajeev M. | Director | Buy | 533,333 | $15.00 | $7,999,995.00 | +33.8% | |
| Jul 25, 2017 | Grunberg Gregory | Director | Buy | 215,000 | $15.00 | $3,225,000.00 | +10.5% | |
| Jul 25, 2017 | Ra Capital Management, LLC53 | Director | Buy | 533,333 | $15.00 | $7,999,995.00 | +33.8% | |
| Jul 20, 2017 | Cdk Associates, L.l.c. | 10% Owner | Buy | 215,000 | $15.00 | $3,225,000.00 | New |